AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.680
+0.010 (0.21%)
At close: Jul 17, 2026, 4:00 PM EDT
4.590
-0.090 (-1.92%)
After-hours: Jul 17, 2026, 5:21 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $168.56 million as of July 17, 2026. Its market cap has increased by 417.20% in one year.
Market Cap
168.56M
Enterprise Value
83.27M
1-Year Change
417.20%
Ranking
Category
Stock Price
$4.68
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $168.56M, a decrease of -40.04%. That is a compound annual growth rate of -11.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 168.56M | 439.58% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YD Bio | 173.69M |
| Tenaya Therapeutics | 173.47M |
| Arcturus Therapeutics Holdings | 173.10M |
| Outlook Therapeutics | 169.81M |
| OnKure Therapeutics | 169.66M |
| Corbus Pharmaceuticals Holdings | 167.49M |
| Alector | 167.09M |
| Jyong Biotech | 167.03M |